Incyte to Report Third Quarter Financial Results

Incyte Corporation (Nasdaq:INCY) announced today that it has scheduled its third quarter 2018 financial results conference call and webcast for 8:00 a.m. ET on Tuesday, October 30, 2018.

The schedule for the press release and conference call/webcast is as follows:

¢

Q3 2018 Press Release:

October 30, 2018 at 7:00 a.m. ET

¢

WANT TO BUILD A FINANCIAL EMPIRE?

Subscribe to the Global Banking & Finance Review Newsletter for FREE
Get Access to Exclusive Reports to Save Time & Money

By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.
All emails include an unsubscribe link. You may opt-out at any time. See our privacy policy.

Q3 2018 Conference Call:

October 30, 2018 at 8:00 a.m. ET

¢

Domestic Dial-In Number:

877-407-3042

¢

International Dial-In Number:

201-389-0864

¢

Conference ID Number:

13683637

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13683637.

The live webcast with slides can be accessed at www.incyte.com under For Investors, Events and Presentations and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s website at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

Incyte Corporation
Investors
Michael Booth, DPhil, +1
302-498-5914
[email protected]
or
Media
Catalina
Loveman, +1 302-498-6171
[email protected]